Page 342 - ASHG 2013 Program Guide

SPEAKER AND AUTHOR DISCLOSURES
  323
SPEAKER/AUTHOR DISCLOSURES
Hollox, E. J., Pfizer - 2 (695W)
Holm, I. A., Alexion International - 15; Novartis
Pharmaceutical Corp. - 5; Perceptive Informatics,
Inc - 5; Data Monitoring Committee (Session 41)
Hoover, A., GenoLogics Scientific Software - 3
(1608
W)
Horner, V. L., Emory Genetics Lab - 3 (2885W)
Huizing, M., NIH (W.A.G and M.H.) - 10 (2385T)
Hwang, V., Bio-Rad Laboratories - 15; unpaid
collaboration (2590F)
Jensen, T., Sequenom Center for Molecular Medicine -
3;
Sequenom, Inc - 1 (434T)
Jeong, K., Agilent Technologies - 3 (1657T)
Jia, P., MolecularMD - 5, 10; Illumina Inc - 14 (3460T)
Jimenez, D., FAP-DF - 14; CAPES - 2; CNPq - 2
(2098
F)
Johnson, K. J., Novartis - 3 (3136F)
Johnston, J. J., Illumina - 11; Genentech - 7 (2451W)
Jonsson, J. J., Lífeind/BioCule Inc. - 4, 6, 10 (2527F)
Jorgez, C., Signature Genomic Laboratories - 3
(2643
W)
Kamberov, E., Rubicon Genomics - 1, 3, 10 (1693T)
Kasturi, V., Genzyme - 2, 5; Amicus - 5 (2387T)
Katayama, J., Life Technologies, - 3 (3324W)
Kaufman, J., Annai Systems - 1, 3 (1468T)
Kaushik, P., Myriad Genetic Laboratories, Inc. - 1, 3
(3446
F)
Kawahara, G., Pfizer Inc. - 12 (2280F)
Kehoe, L. S., Genzyme Corporation - 2 (2373T)
Kennedy, C., Good Start Genetics - 1, 3, 10 (1470W)
Kim, R. H., K Nykamp (Prevention Genetics) - 3
(3144
T)
King, D. P., AbbVie Inc. - 1, 3 (706W)
Kishnani, P. S., Genzyme - 2, 11, 14 (2291T)
Kobayashi, Y., InVitae - 3 (3309W)
Lachowicz, J. E., Angiochem - 3 (2288F)
Laig, M., Life Technologies - 3; American Red Cross -
12;
Diatherix Laboratories, Inc - 15; former
employee (2602F)
Langmore, J., Rubicon Genomics - 1, 3, 10 (1671W)
Lasko, P., IRDiRC - 6 (3149W)
Lau, L. Y., Life Technologies - 12 (2585W)
Lee, I. H., Illumina, Inc. - 3 (1683W)
Lee, M. M., Fluidigm Inc - 3 (1677W)
Leger, A. J., Genzyme - 1, 3 (2318F)
León, D., Life Technologies - 3 (1474T)
Letovsky, S., SynapDx - 3, 1 (1226W)
Levy, B., Natera, Inc. - 5 (2860T)
Li, C., Amgen Inc - 1, 3 (674W)
Li, H., National Natural Science Foundation - 2 (637F)
Li, Y., Novartis Institutes for Biomedical Research - 3
(718
W)
Lincoln, S., InVitae - 1, 3, 4 (2550T)
Lins, T., FAP-DF - 14; CAPES - 2; CNPq - 2 (2099W)
Linse Peterson, G., Golden Helix - 3 (1591T)
Lippert, C., Microsoft - 1, 3 (1735F)
Listgarten, J., Microsoft - 3 (1779T)
Liu, P., New England Biolabs - 3 (1598F)
Lutz, M. W., Zinfandel Pharmaceuticals - 5 (1715W)
Lyon, G. J., Omicia - 3; Assure Rx - 3 (3087T)
Ma, L., Abbott - 5 (149)
Maar, D., Bio-Rad Laboratories - 3 (686W)
Maltbie, D., Annai Systems - 1, 3, 5, 10 (1480T)
Mancini-DiNardo, D., Myriad Genetic Laboratories, Inc.
- 1, 3;
Myriad Genetics, Inc. - 1, 3 (408)
Mankoski, R., Genzyme - 3 (2275T)
Mardis, E., Pacific Biosciences - 11; Illumina Inc - 8;
Life Technologies - 1 (Session 72)
Marino, J., CAPES Coordination Improvement of
Higher Education Personnel - 2 (3173W)
Marshall, J., Genzyme - 1, 3 (2272F)
Marth, G., Edge Biosystems - 5; Omicia, Inc. - 5
(
Session 8)
Martignetti, J. A., Station X, Inc. - 12 (3402W)
Martin, C. L., CellScape - 14 (Session 37)
Martis, S., MRC Holland - 3 (701W)
Mason, C., BD Biosciences - 3; NanoString
Technologies - 3 (1673F)
Mason-Suares, H., Emory Genetics Laboratory - 3
(2995
F)
McAdoo, S., Natera - 3 (2863W)
Melsted, P., deCODE Genetics - 3 (1488W)
Milnik, A., SNF Sinergia Grant CRSIK0_122691 - 2;
SNF Sinergia Grant CRSI33_130080 - 2; ADAMS
Project, HEALTH-F4-2009-242257 - 2 (1320T)
Mittelman, D., Arpeggi, Inc. - 1, 11 (1592F)
Mollon, J. E., SomaLogic - 3, 12 (1694W)
Molony, C. M., Merck - 1, 3 (962F)
Montano, A., Ultragenyx Pharmaceutical Inc. - 2
(2375
T)
Mooney, K., BioMarin - 1, 3 (2404F)
Moore, J. K., PerkinElmer, Inc - 1, 3 (1400W)
Moreland, R. J., Genzyme - 1, 3 (2388F)
Morford, L. A., University of Kentucky - 3 (2948W)
Mueller, P., Roche Applied Science - 9; Asuragen - 9
(2553
T)
Munafo, D., New England Biolabs, Inc. - 3 (1674W)
Musci, T., Ariosa Diagnostics, Inc - 1, 3 (2603W)
Natt, P., National Institute of Diabetes and Digestive
and Kidney Diseases - 2; National Genome
Research Institute - 2 (2184W)
Neitzel, D., Good Start Genetics - 1, 3 (2543W)
Nelson, M. R., GlaxoSmithKline - 3 (321)
Novembre, J., Ancestry.com - 11, 5, 6 (Session 8)
Okada, Y., Genentech - 3 (339)
Olfson, E., National Institute of General Medical
Sciences - 2; National Center for Advancing
Translational Sciences - 2 (2469W)
Olsen, C., Biomatters - 1 (1629W)
O’Roak, B. J., Yale University - 7, 10 (360)
Ozsolak, F., RaNA Therapeutics - 1 (2269T)
Packman, S., Genzyme - 2 (2276F)
Park, H. J., Roche - 9 (2843W)
Pasquale, L., Genentech, Inc - 3 (1030T)
Passini, M. A., Genzyme - 1, 3, 10 (2301T)
Pastores, G., Genzyme - 2, 8; Actelionn - 8
(
Session 42)
Paz, A., Protalix Biotherapeutics - 3 (2292F)
Pearson, C. E., Prosensa - 5, 11 (1408F)
Pearson, N. M., Ingenuity Systems - 3 (102)
Pease, J., Epicentre - 3 (622F)
Perreault-Micale, C. L., Good Start Genetics - 3 (568F)
Peters, T., Novartis Pharma AG - 3 (1666T)
Porreca, G. J., Good Start Genetics - 1, 3, 10 (2537W)
Prabhu, S., Silicon Valley Biosystems - 3 (53)
Prasad, S., BioMarin - 3 (2399T)